Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C: Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens. 2008, 26: 2064-2070. 10.1097/HJH.0b013e32830c45c3.
Article
CAS
PubMed
Google Scholar
Farsang C, Naditch-Brule L, Perlini S, Zidek W, Kjeldsen SE: Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. J Hum Hypertens. 2009, 23: 316-324. 10.1038/jhh.2008.136.
Article
CAS
PubMed
Google Scholar
Ritchie SA, Ewart MA, Perry CG, Connell JM, Salt IP: The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci (Lond). 2004, 107: 519-532.
Article
CAS
Google Scholar
Aldhahi W, Hamdy O: Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep. 2003, 3: 293-298. 10.1007/s11892-003-0020-2.
Article
PubMed
Google Scholar
Guerre-Millo M: Adipose tissue and adipokines: for better or worse. Diabetes Metab. 2004, 30: 13-19. 10.1016/S1262-3636(07)70084-8.
Article
CAS
PubMed
Google Scholar
Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S: Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005, 288: H2031-2041. 10.1152/ajpheart.01058.2004.
Article
CAS
PubMed
Google Scholar
Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, Ong LH, Tam S, Tan KC, Janus ED: Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension. 2007, 49: 1455-1461. 10.1161/HYPERTENSIONAHA.107.086835.
Article
CAS
PubMed
Google Scholar
Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, Kumada M, Ohashi K, Okamoto Y, Nishizawa H: Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003, 42: 231-234. 10.1161/01.HYP.0000083488.67550.B8.
Article
CAS
PubMed
Google Scholar
Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, Chan L, Goldstein BJ, Scalia R: Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest. 2007, 117: 1718-1726. 10.1172/JCI29623.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, Lam KS: Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab. 2004, 89: 765-769. 10.1210/jc.2003-031012.
Article
CAS
PubMed
Google Scholar
Hattori Y, Hattori S, Akimoto K, Nishikimi T, Suzuki K, Matsuoka H, Kasai K: Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts. Diabetes. 2007, 56: 804-808. 10.2337/db06-1405.
Article
CAS
PubMed
Google Scholar
Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003, 278: 45021-45026. 10.1074/jbc.M307878200.
Article
CAS
PubMed
Google Scholar
Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, Muellner C, Speiser W, Wagner O: Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res. 2002, 90: 711-718. 10.1161/01.RES.0000014226.74709.90.
Article
CAS
PubMed
Google Scholar
Bouloumie A, Marumo T, Lafontan M, Busse R: Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999, 13: 1231-1238.
CAS
PubMed
Google Scholar
Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003, 289: 1799-1804. 10.1001/jama.289.14.1799.
Article
CAS
PubMed
Google Scholar
Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000, 11: 327-332. 10.1016/S1043-2760(00)00301-5.
Article
CAS
PubMed
Google Scholar
Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP: Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens. 1994, 12: 1433-1437. 10.1097/00004872-199412000-00018.
Article
CAS
PubMed
Google Scholar
Hall JE, Hildebrandt DA, Kuo J: Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001, 14: 103S-115S. 10.1016/S0895-7061(01)02077-5.
Article
CAS
PubMed
Google Scholar
Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM: Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002, 324: 127-137. 10.1097/00000441-200209000-00003.
Article
PubMed
Google Scholar
Garrison RJ, Kannel WB, Stokes J, Castelli WP: Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987, 16: 235-251. 10.1016/0091-7435(87)90087-9.
Article
CAS
PubMed
Google Scholar
Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ: Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008, 52: 818-827. 10.1161/HYPERTENSIONAHA.108.113357.
Article
CAS
PubMed
Google Scholar
Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY: Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med. 2004, 140: 992-1000.
Article
PubMed
Google Scholar
Wildman RP, Sutton-Tyrrell K, Newman AB, Bostom A, Brockwell S, Kuller LH: Lipoprotein levels are associated with incident hypertension in older adults. J Am Geriatr Soc. 2004, 52: 916-921. 10.1111/j.1532-5415.2004.52258.x.
Article
PubMed
Google Scholar
Nofer JR, Giet van der M, Tolle M, Wolinska I, von Wnuck Lipinski K, Baba HA, Tietge UJ, Godecke A, Ishii I, Kleuser B: HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest. 2004, 113: 569-581.
Article
PubMed Central
CAS
PubMed
Google Scholar
Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G: The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens. 2008, 26: 1891-1900. 10.1097/HJH.0b013e328302ca38.
Article
CAS
PubMed
Google Scholar
Hanefeld M, Koehler C, Gallo S, Benke I, Ott P: Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol. 2007, 6: 13-10.1186/1475-2840-6-13.
Article
PubMed Central
PubMed
Google Scholar
Comments
View archived comments (1)